HK:3759 Pharmaron Beijing Ltd H

Pharmaron Beijing Co., Ltd. provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through four segments: Laboratory Services, Manufacturing and Controls (CMC) Services, Clinical Development, and Others. It offers laboratory chemistry, drug metabolism and pharmacokinetics/absorption, distribution, metabolism and excretion, and in vitro biology and in vivo pharmacology services, as well as safety assessment and discovery biologics services; process development and manufacturing, material science/pre-formulation, formulation development and manufacturing, and analytical development services; and clinical research, site management, regulatory bioanalysis, and radiolabelled science services. The company also provides business development, contract research, and development and manufacturing services for pharmaceutical products. Pharmaron Beijing Co., Ltd. was founded in 2004 and is headquartered in Beijing, the People's Republic of China.

185.60 USD
As of 06/15/2021


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  China
IPO date:  11/28/2019
Stock exchange:    Hong Kong Exchange
Exchange country:   Hong Kong
Market cap:   0 USD
Current dividend yield:   0.00%
CUSIP:    
ISIN:        CNE100003PG4
Sedol:      BK72QD3

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy